CN113016972A - 一种含有园艺黄荆的固体饮料 - Google Patents
一种含有园艺黄荆的固体饮料 Download PDFInfo
- Publication number
- CN113016972A CN113016972A CN201911354309.XA CN201911354309A CN113016972A CN 113016972 A CN113016972 A CN 113016972A CN 201911354309 A CN201911354309 A CN 201911354309A CN 113016972 A CN113016972 A CN 113016972A
- Authority
- CN
- China
- Prior art keywords
- parts
- leaves
- extract
- solid beverage
- negundo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 30
- 239000007787 solid Substances 0.000 title claims abstract description 30
- 241001643642 Viticis Species 0.000 title description 2
- 244000248021 Vitex negundo Species 0.000 claims abstract description 52
- 235000013427 Vitex negundo var incisa Nutrition 0.000 claims abstract description 32
- 235000014961 Vitex negundo var negundo Nutrition 0.000 claims abstract description 32
- 235000014956 negundo chastetree Nutrition 0.000 claims abstract description 32
- 240000000249 Morus alba Species 0.000 claims abstract description 30
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 239000003755 preservative agent Substances 0.000 claims abstract description 23
- 235000010363 Vitex negundo Nutrition 0.000 claims abstract description 20
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 18
- 244000075850 Avena orientalis Species 0.000 claims abstract description 18
- 240000006162 Chenopodium quinoa Species 0.000 claims abstract description 18
- 244000045195 Cicer arietinum Species 0.000 claims abstract description 18
- 235000010523 Cicer arietinum Nutrition 0.000 claims abstract description 18
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims abstract description 18
- 241001018563 Nekemias grossedentata Species 0.000 claims abstract description 18
- 244000046052 Phaseolus vulgaris Species 0.000 claims abstract description 18
- 235000006533 astragalus Nutrition 0.000 claims abstract description 18
- 235000004426 flaxseed Nutrition 0.000 claims abstract description 18
- 235000021332 kidney beans Nutrition 0.000 claims abstract description 18
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 17
- 241001233914 Chelidonium majus Species 0.000 claims abstract description 17
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 12
- 241000207199 Citrus Species 0.000 claims abstract description 12
- 229920002752 Konjac Polymers 0.000 claims abstract description 12
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 12
- 239000000835 fiber Substances 0.000 claims abstract description 12
- 235000010485 konjac Nutrition 0.000 claims abstract description 12
- 235000020232 peanut Nutrition 0.000 claims abstract description 12
- 235000004976 Solanum vernei Nutrition 0.000 claims abstract description 9
- 241000352057 Solanum vernei Species 0.000 claims abstract description 9
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims abstract description 5
- 240000008620 Fagopyrum esculentum Species 0.000 claims abstract 4
- 238000002360 preparation method Methods 0.000 claims description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- 241000196252 Ulva Species 0.000 claims description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 21
- 210000000582 semen Anatomy 0.000 claims description 21
- 238000001694 spray drying Methods 0.000 claims description 21
- 230000002335 preservative effect Effects 0.000 claims description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 241000220261 Sinapis Species 0.000 claims description 14
- 235000013399 edible fruits Nutrition 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- 230000002421 anti-septic effect Effects 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 108090000526 Papain Proteins 0.000 claims description 7
- 239000004365 Protease Substances 0.000 claims description 7
- 229940055729 papain Drugs 0.000 claims description 7
- 235000019834 papain Nutrition 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002244 precipitate Substances 0.000 claims description 7
- 230000001376 precipitating effect Effects 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 229940031518 ulva lactuca extract Drugs 0.000 claims description 7
- 244000017020 Ipomoea batatas Species 0.000 claims description 3
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 3
- 235000015493 Chenopodium quinoa Nutrition 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 40
- 210000004369 blood Anatomy 0.000 abstract description 40
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 19
- 230000001603 reducing effect Effects 0.000 abstract description 15
- 230000009982 effect on human Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 34
- 239000004615 ingredient Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- 241000411851 herbal medicine Species 0.000 description 18
- 241000219051 Fagopyrum Species 0.000 description 14
- 244000063464 Vitex agnus-castus Species 0.000 description 14
- 235000009347 chasteberry Nutrition 0.000 description 14
- 239000003814 drug Substances 0.000 description 14
- 235000001667 Vitex agnus castus Nutrition 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 12
- 235000015872 dietary supplement Nutrition 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 8
- 230000004071 biological effect Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 244000223014 Syzygium aromaticum Species 0.000 description 6
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 244000000010 microbial pathogen Species 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 230000002035 prolonged effect Effects 0.000 description 6
- 230000002195 synergetic effect Effects 0.000 description 6
- 244000056139 Brassica cretica Species 0.000 description 5
- 235000003351 Brassica cretica Nutrition 0.000 description 5
- 235000003343 Brassica rupestris Nutrition 0.000 description 5
- 235000008671 Calycanthus floridus Nutrition 0.000 description 5
- 244000025311 Calycanthus occidentalis Species 0.000 description 5
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 5
- 235000004520 Lindera benzoin Nutrition 0.000 description 5
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 5
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000010030 glucose lowering effect Effects 0.000 description 5
- 235000010460 mustard Nutrition 0.000 description 5
- PJQLSMYMOKWUJG-UHFFFAOYSA-N casticin Chemical compound C1=C(O)C(OC)=CC=C1C1=C(OC)C(=O)C2=C(O)C(OC)=C(OC)C=C2O1 PJQLSMYMOKWUJG-UHFFFAOYSA-N 0.000 description 4
- CCWSQXBMKLEALQ-WMZOPIPTSA-N centaureidin Natural products CO[C@@H]1[C@@H](Oc2cc(O)c(OC)c(O)c2C1=O)c3ccc(OC)c(O)c3 CCWSQXBMKLEALQ-WMZOPIPTSA-N 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- DTPRTOXMYKYSIJ-UHFFFAOYSA-N eupatorin Natural products C1=C(O)C(OC)=CC=C1C1=CC(=O)C2=CC(OC)=C(OC)C=C2O1 DTPRTOXMYKYSIJ-UHFFFAOYSA-N 0.000 description 4
- 208000030159 metabolic disease Diseases 0.000 description 4
- HKMZDYJMJDPXRP-UHFFFAOYSA-N vitexicarpin Natural products OC1=C2C(C(=C(OC2=CC(=C1OC)OC)C1=CC(=CC(=C1)OC)O)OC)=O HKMZDYJMJDPXRP-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 2
- RXBQNMWIQKOSCS-UHFFFAOYSA-N (7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methanol Chemical compound C1C2C(C)(C)C1CC=C2CO RXBQNMWIQKOSCS-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- IGODOXYLBBXFDW-UHFFFAOYSA-N alpha-Terpinyl acetate Chemical compound CC(=O)OC(C)(C)C1CCC(C)=CC1 IGODOXYLBBXFDW-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000010413 gardening Methods 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- IOYHCQBYQJQBSK-UHFFFAOYSA-N orobol Chemical compound C=1C(O)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 IOYHCQBYQJQBSK-UHFFFAOYSA-N 0.000 description 2
- -1 pinene Chemical compound 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 1
- ODBRNZZJSYPIDI-UHFFFAOYSA-N 3',4',5,7-tetrahydroxy-6-C-glucopyranosylflavone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- RTATXGUCZHCSNG-TYSPDFDMSA-N Kaempferol-3-O-rutinoside Natural products OC1[C@H](O)[C@@H](O)C(C)O[C@H]1OCC1[C@@H](O)[C@@H](O)C(O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-TYSPDFDMSA-N 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- RXBQNMWIQKOSCS-RKDXNWHRSA-N Myrtenol Natural products C1[C@H]2C(C)(C)[C@@H]1CC=C2CO RXBQNMWIQKOSCS-RKDXNWHRSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- RTATXGUCZHCSNG-QHWHWDPRSA-N Nicotiflorin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-QHWHWDPRSA-N 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- WJJFWGUVMIUWGG-UHFFFAOYSA-N Stereolensin Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O WJJFWGUVMIUWGG-UHFFFAOYSA-N 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 241001073567 Verbenaceae Species 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- IGODOXYLBBXFDW-NSHDSACASA-N alpha-Terpinyl acetate Natural products CC(=O)OC(C)(C)[C@@H]1CCC(C)=CC1 IGODOXYLBBXFDW-NSHDSACASA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930009668 farnesene Natural products 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 230000007849 functional defect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- ODBRNZZJSYPIDI-VJXVFPJBSA-N isoorientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=C(O)C(O)=CC=3)C2=C1O ODBRNZZJSYPIDI-VJXVFPJBSA-N 0.000 description 1
- UYJGIAWJIRZBNU-UHFFFAOYSA-N isoorientin Natural products OCC1OC(C(O)C(O)C1O)c2cc(O)c(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4 UYJGIAWJIRZBNU-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019508 mustard seed Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- RTATXGUCZHCSNG-ZFDPGQBLSA-N nicotiflorin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O)c3)C2=O)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 RTATXGUCZHCSNG-ZFDPGQBLSA-N 0.000 description 1
- RTATXGUCZHCSNG-UHFFFAOYSA-N nicotiflorine Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 RTATXGUCZHCSNG-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/115—Konjak; Konntaku
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种含有园艺黄荆的固体饮料,其原料包括:园艺黄荆叶13‑15份、穗花牡荆种子4‑7份、密花千屈菜2‑3份、桑叶2‑4份、显齿蛇葡萄叶2‑3份、黄芪叶2‑5份、魔芋5‑10份、花生3‑6份、紫薯2‑4份、桑叶1‑3份、柑橘纤维3‑7份、白芸豆6‑11份、鹰嘴豆2‑5份、亚麻籽3‑4份、藜麦2‑3份、燕麦2‑4份、荞麦3‑6份、防腐制剂0.5‑1份。本发明对人类Ⅱ型糖尿病有较好的治疗作用,对降低血糖有积极的意义,且对园艺黄荆叶的新用途具有指导性。
Description
技术领域
本发明涉及园艺黄荆技术领域,具体涉及一种含有园艺黄荆的固体饮料。
背景技术
近几十年来我国成人糖尿病患病率显著增加。糖尿病是一组以高血糖为特征的代谢性疾病,而高血糖是由于胰岛素分泌缺陷或其生物作用受损,或两者兼有引起。人体内胰岛素分泌不足,导致糖、蛋白质和水电解质代 谢紊乱而引起的疾病,它直接破坏心、脑、肾、眼及神经组织器官,是继肿瘤和心血管疾病之后的较难治愈的第三大非传染性疾病,常常导致碳水化合物,蛋白质,脂肪及水和电解质代谢紊乱造成患者人体各种组织,特别是脾胃、肾脏、神经、心脏及血管的损伤,功能缺陷和衰竭。糖尿病的发病机制目前仍然不是十分清楚,Ⅱ型糖尿病一般受遗传因素、肥胖、饮食及运动不足等影响,导致胰岛素分泌障碍及作用不足而引发的代谢障碍,是一种慢性代谢疾病,其伴随葡萄糖的过剩,体脂肪的分解及蛋白质的浪费,且胰高血糖素的分泌非正常亢进,进而引发代谢紊乱,因此糖尿病导致体内代谢功能异常,出现高血糖症糖通过尿液排出,会导致循环系统的并发症。目前治疗方法主要有药物治疗,常规治疗糖尿病的药物主要是口服药物(磺脲类药物、胰岛素增敏剂、双胍类降糖药、α葡萄糖苷酶抑制剂)和长期注射胰岛素治疗,但其均有不同程度的副作用。
园艺黄荆是穗花牡荆中的一个优秀品种,为马鞭草科牡荆属小型落叶乔木或灌木植物,全株均有香味。小枝方形,密生灰白色绒毛。叶对生,掌状出复叶,小叶片边缘有多数锯齿,上面绿色,下面淡绿色,无毛或稍有毛。圆锥状花序顶生硕大,花钟形,顶端有齿裂花冠紫蓝色、亮丽,顶端有裂片。果实球形,黄褐色至棕褐色,形状似黑胡椒子,有辛辣香味。
穗花牡荆是欧洲的常用草药之一,其对疾病的治疗作用已得到了美国、德国、日本等国家的认可。据文献记载,早在2500年前,穗花牡荆果实就被用于治疗妇科疾病,如痛经、月经不调等,并传说其常用于牧师和教士,以减少其性欲。此外自古希腊以来其果实就一直被用做妇女保健植物药。在土耳其,居民用穗花牡荆叶子来治疗腹痛,果实被用于利尿,驱风,镇静,而花、叶和根茎用于治疗月经周期紊乱;在巴西,穗花牡荆嫩枝与果实也用于治疗胃痛、头痛和梅毒等;在伊朗民间,穗花牡荆被用来治疗乳汁不畅、惊厥、癫痫、便秘等。随着国外学者对穗花牡荆研究的不断深入,逐渐发现穗花牡荆具有雌激素样作用,对女性疾病有很好的疗效,德国也于1992年将穗花牡荆果实提取物批准用于治疗月经不调、经前期综合征和乳腺痛,同时穗花牡荆果实也被载入欧洲药典,使其有明确的药用标准。穗花牡荆含有众多具有生物活性的化学成分。紫花牡荆素是穗花牡荆的主要化学成分和标志性成分,在《欧洲药典》中规定,穗花牡荆果实中紫花牡荆素的含量不低于0.8%,可发挥纵多生物活性,如抗炎、抗肿瘤、抑制催乳素分泌等。穗花牡荆中还含有丰富的挥发油成分,主要包括桉树脑、桃金娘烯醇、蒎烯、香桧烯、法呢烯、牛儿烯、石竹烯和α-乙酸松油酯等;黄酮类,如芹菜素、木犀草素、山柰酚-3-O-芸香糖苷、异木犀草素6-c-(2-O-反式咖啡基)葡萄糖苷、牡荆黄素和异东方蓼黄素等;酚酸类,如羟基苯甲酸、3,4-二羟基苯甲酸等。此外还含有类胡萝卜素、绿原酸、异绿原酸等,具有抗氧化作用。
目前将园艺黄荆叶用于制备固体饮料鲜有报道,经研究,园艺黄荆叶经与其它物料组成配方后可对人类Ⅱ型糖尿病有较好的治疗作用,将其作为具有保健作用的固体饮料的原料组分或能取得意料不到的效果。
发明内容
发明目的:本发明目的在于针对现有技术的不足,提供一种含有园艺黄荆的固体饮料,该固体饮料对人类Ⅱ型糖尿病有较好的治疗作用,对降低血糖有积极的意义,且对园艺黄荆叶的新用途具有指导性。
技术方案:本发明所述一种含有园艺黄荆的固体饮料,按照组份的质量份数配比包括下述原料:园艺黄荆叶13-15份、穗花牡荆种子4-7份、密花千屈菜2-3份、桑叶2-4份、显齿蛇葡萄叶2-3份、黄芪叶2-5份、魔芋5-10份、花生3-6份、紫薯2-4份、桑叶1-3份、柑橘纤维3-7份、白芸豆6-11份、鹰嘴豆2-5份、亚麻籽3-4份、藜麦2-3份、燕麦2-4份、荞麦3-6份、防腐制剂0.5-1份。
优选地,按照组份的质量份数配比包括下述原料:园艺黄荆叶13.5-14.5份、穗花牡荆种子5-6.5份、密花千屈菜2.2-2.7份、桑叶2.4-3.8份、显齿蛇葡萄叶2.1-2.6份、黄芪叶3-4.5份、魔芋6-8份、花生4.5-5.5份、紫薯2.3-3.6份、桑叶1.8-2.6份、柑橘纤维4-6份、白芸豆8-10份、鹰嘴豆3-4.5份、亚麻籽3.2-3.7份、藜麦2.3-2.6份、燕麦2.5-3.5份、荞麦4-5.5份、防腐制剂0.6-0.9份。
优选地,按照组份的质量份数配比包括下述原料:园艺黄荆叶14份、穗花牡荆种子6份、密花千屈菜2.5份、桑叶3份、显齿蛇葡萄叶2.4份、黄芪叶4份、魔芋7份、花生5份、紫薯3份、桑叶2份、柑橘纤维5份、白芸豆9份、鹰嘴豆4份、亚麻籽3.5份、藜麦2.5份、燕麦3份、荞麦5份、防腐制剂0.7份。
优选地,所述防腐制剂的制备方法包括下述步骤:
S1、取芥子,用水煎煮2-3次,合并浓缩液,将浓缩液减压浓缩、喷雾干燥得芥子提取物;
S2、取丁香,以甲醇溶液提取1-2次,再用乙醚萃取,回收溶剂,将溶剂减压浓缩、喷雾干燥得丁香提取物;
S3、取石莼,加工成石莼粉溶液,加入木瓜蛋白酶进行酶解,经真空浓缩,再用乙醇沉淀并旋转15-20min,将沉淀物用丙酮洗脱并喷雾干燥,得石莼提取物;
S4、将芥子提取物、丁香提取物和石莼提取物混合均匀即得防腐制剂。
优选地,S2中,甲醇溶液的质量分数为85-90wt%。
优选地,S3中,酶解中,pH为6.5-7,温度为50-55℃,时间为3-4h。
优选地,S3中,旋转的转速为4000-4500r/min。
本发明在制备时,将各原料研磨干燥成粉末状混合物即可。
与现有技术相比,本发明的有益效果为:(1)本发明原料来源广泛,成本低廉,贮存期2-3年,具有较好的保健作用,尤其对于Ⅱ型糖尿病具有较好的降低血糖的效果。(2)本发明以园艺黄荆叶作为主植物性成分,穗花牡荆种子、密花千屈菜、桑叶、显齿蛇葡萄叶、黄芪叶作为辅助植物性成分,含有众多具有生物活性的化学成分,配合作用具有较好的降血糖效果。(3)本发明另加入白芸豆、鹰嘴豆、亚麻籽、藜麦、燕麦、荞麦等营养补充物,能够丰富本发明的保健功效,其与园艺黄荆种子等植物性成分具有协效作用,能够显著提高本发明降低血糖的效果。(4)本发明另加入防腐制剂,优选芥子提取物、丁香提取物和石莼提取物的中药复合物,根据每种中草药的不同特性,分别提取分离中草药有效成分后配制而成,使三种中草药的药理作用起到相辅相成的效果,有效控制病原微生物的生长繁殖及传播,提高本发明的保质期,同时提高本发明的口感和风味。
具体实施方式
下面通过具体实施例对本发明技术方案进行详细说明,但是本发明的保护范围不局限于所述实施例。
实施例1
一种含有园艺黄荆的固体饮料,按照组份的质量份数配比包括下述原料:园艺黄荆叶13份、穗花牡荆种子7份、密花千屈菜2份、桑叶4份、显齿蛇葡萄叶2份、黄芪叶5份、魔芋5份、花生6份、紫薯2份、桑叶3份、柑橘纤维3份、白芸豆11份、鹰嘴豆2份、亚麻籽4份、藜麦2份、燕麦4份、荞麦3份、防腐制剂1份。
其中,所述防腐制剂的制备方法包括下述步骤:
S1、取芥子,用水煎煮3次,合并浓缩液,将浓缩液减压浓缩、喷雾干燥得芥子提取物;
S2、取丁香,以85wt%甲醇溶液提取2次,再用乙醚萃取,回收溶剂,将溶剂减压浓缩、喷雾干燥得丁香提取物;
S3、取石莼,加工成石莼粉溶液,加入木瓜蛋白酶在pH为6.5,温度为55℃下酶解3h,经真空浓缩,再用乙醇沉淀并在4500r/min的转速下旋转15min,将沉淀物用丙酮洗脱并喷雾干燥,得石莼提取物;
S4、将芥子提取物、丁香提取物和石莼提取物混合均匀即得防腐制剂。
本实施例在制备时,将各原料研磨干燥成粉末状混合物即可。
本实施例原料来源广泛,成本低廉,贮存期2-3年,具有较好的保健作用,尤其对于Ⅱ型糖尿病具有较好的降低血糖的效果。本实施例以园艺黄荆叶作为主植物性成分,穗花牡荆种子、密花千屈菜、桑叶、显齿蛇葡萄叶、黄芪叶作为辅助植物性成分,含有众多具有生物活性的化学成分,配合作用具有较好的降血糖效果。本实施例另加入白芸豆、鹰嘴豆、亚麻籽、藜麦、燕麦、荞麦等营养补充物,能够丰富本实施例的保健功效,其与园艺黄荆种子等植物性成分具有协效作用,能够显著提高本实施例降低血糖的效果。本实施例另加入防腐制剂,选择芥子提取物、丁香提取物和石莼提取物的中药复合物,根据每种中草药的不同特性,分别提取分离中草药有效成分后配制而成,使三种中草药的药理作用起到相辅相成的效果,有效控制病原微生物的生长繁殖及传播,提高本实施例的保质期,同时提高本实施例的口感和风味。
测试本实施例的降糖效果:随机选取40-60岁之间的Ⅱ型糖尿病患者100名,每位Ⅱ型糖尿病患者于每天晚饭后开水冲服本实施例配制的含有园艺黄荆的固体饮料50-100g,连续服用45天后,上述100名Ⅱ型糖尿病患者中,90名患者的血糖水平有了明显地降低,10名患者的血糖水平控制在平稳状态,不再上升。由此可知本实施例具有降血糖效果显著的特点,且适于Ⅱ型糖尿病人长期食用。
实施例2
一种含有园艺黄荆的固体饮料,按照组份的质量份数配比包括下述原料:园艺黄荆叶15份、穗花牡荆种子4份、密花千屈菜3份、桑叶2份、显齿蛇葡萄叶3份、黄芪叶2份、魔芋10份、花生3份、紫薯4份、桑叶1份、柑橘纤维7份、白芸豆6份、鹰嘴豆5份、亚麻籽3份、藜麦3份、燕麦2份、荞麦6份、防腐制剂0.5份。
其中,所述防腐制剂的制备方法包括下述步骤:
S1、取芥子,用水煎煮2次,合并浓缩液,将浓缩液减压浓缩、喷雾干燥得芥子提取物;
S2、取丁香,以90wt%甲醇溶液提取1次,再用乙醚萃取,回收溶剂,将溶剂减压浓缩、喷雾干燥得丁香提取物;
S3、取石莼,加工成石莼粉溶液,加入木瓜蛋白酶在pH为7,温度为50℃下酶解4h,经真空浓缩,再用乙醇沉淀并在4000r/min的转速下旋转20min,将沉淀物用丙酮洗脱并喷雾干燥,得石莼提取物;
S4、将芥子提取物、丁香提取物和石莼提取物混合均匀即得防腐制剂。
本实施例在制备时,将各原料研磨干燥成粉末状混合物即可。
本实施例原料来源广泛,成本低廉,贮存期2-3年,具有较好的保健作用,尤其对于Ⅱ型糖尿病具有较好的降低血糖的效果。本实施例以园艺黄荆叶作为主植物性成分,穗花牡荆种子、密花千屈菜、桑叶、显齿蛇葡萄叶、黄芪叶作为辅助植物性成分,含有众多具有生物活性的化学成分,配合作用具有较好的降血糖效果。本实施例另加入白芸豆、鹰嘴豆、亚麻籽、藜麦、燕麦、荞麦等营养补充物,能够丰富本实施例的保健功效,其与园艺黄荆种子等植物性成分具有协效作用,能够显著提高本实施例降低血糖的效果。本实施例另加入防腐制剂,选择芥子提取物、丁香提取物和石莼提取物的中药复合物,根据每种中草药的不同特性,分别提取分离中草药有效成分后配制而成,使三种中草药的药理作用起到相辅相成的效果,有效控制病原微生物的生长繁殖及传播,提高本实施例的保质期,同时提高本实施例的口感和风味。
测试本实施例的降糖效果:随机选取40-60岁之间的Ⅱ型糖尿病患者200名,每位Ⅱ型糖尿病患者于每天晚饭后开水冲服本实施例配制的含有园艺黄荆的固体饮料50-100g,连续服用45天后,上述200名Ⅱ型糖尿病患者中,182名患者的血糖水平有了明显地降低,18名患者的血糖水平控制在平稳状态,不再上升。由此可知本实施例具有降血糖效果显著的特点,且适于Ⅱ型糖尿病人长期食用。
实施例3
一种含有园艺黄荆的固体饮料,按照组份的质量份数配比包括下述原料:园艺黄荆叶14.5份、穗花牡荆种子5份、密花千屈菜2.7份、桑叶2.4份、显齿蛇葡萄叶2.6份、黄芪叶3份、魔芋8份、花生4.5份、紫薯3.6份、桑叶1.8份、柑橘纤维6份、白芸豆8份、鹰嘴豆4.5份、亚麻籽3.2份、藜麦2.6份、燕麦2.5份、荞麦5.5份、防腐制剂0.6份。
其中,所述防腐制剂的制备方法包括下述步骤:
S1、取芥子,用水煎煮3次,合并浓缩液,将浓缩液减压浓缩、喷雾干燥得芥子提取物;
S2、取丁香,以86wt%甲醇溶液提取1次,再用乙醚萃取,回收溶剂,将溶剂减压浓缩、喷雾干燥得丁香提取物;
S3、取石莼,加工成石莼粉溶液,加入木瓜蛋白酶在pH为6.6,温度为52℃下酶解3.5h,经真空浓缩,再用乙醇沉淀并在4200r/min的转速下旋转17min,将沉淀物用丙酮洗脱并喷雾干燥,得石莼提取物;
S4、将芥子提取物、丁香提取物和石莼提取物混合均匀即得防腐制剂。
本实施例在制备时,将各原料研磨干燥成粉末状混合物即可。
本实施例原料来源广泛,成本低廉,贮存期2-3年,具有较好的保健作用,尤其对于Ⅱ型糖尿病具有较好的降低血糖的效果。本实施例以园艺黄荆叶作为主植物性成分,穗花牡荆种子、密花千屈菜、桑叶、显齿蛇葡萄叶、黄芪叶作为辅助植物性成分,含有众多具有生物活性的化学成分,配合作用具有较好的降血糖效果。本实施例另加入白芸豆、鹰嘴豆、亚麻籽、藜麦、燕麦、荞麦等营养补充物,能够丰富本实施例的保健功效,其与园艺黄荆种子等植物性成分具有协效作用,能够显著提高本实施例降低血糖的效果。本实施例另加入防腐制剂,选择芥子提取物、丁香提取物和石莼提取物的中药复合物,根据每种中草药的不同特性,分别提取分离中草药有效成分后配制而成,使三种中草药的药理作用起到相辅相成的效果,有效控制病原微生物的生长繁殖及传播,提高本实施例的保质期,同时提高本实施例的口感和风味。
测试本实施例的降糖效果:随机选取40-60岁之间的Ⅱ型糖尿病患者300名,每位Ⅱ型糖尿病患者于每天晚饭后开水冲服本实施例配制的含有园艺黄荆的固体饮料50-100g,连续服用45天后,上述100名Ⅱ型糖尿病患者中,276名患者的血糖水平有了明显地降低,24名患者的血糖水平控制在平稳状态,不再上升。由此可知本实施例具有降血糖效果显著的特点,且适于Ⅱ型糖尿病人长期食用。
实施例4
一种含有园艺黄荆的固体饮料,按照组份的质量份数配比包括下述原料:园艺黄荆叶13.5份、穗花牡荆种子6.5份、密花千屈菜2.2份、桑叶3.8份、显齿蛇葡萄叶2.1份、黄芪叶4.5份、魔芋6份、花生5.5份、紫薯2.3份、桑叶2.6份、柑橘纤维4份、白芸豆10份、鹰嘴豆3份、亚麻籽3.7份、藜麦2.3份、燕麦3.5份、荞麦4份、防腐制剂0.9份。
其中,所述防腐制剂的制备方法包括下述步骤:
S1、取芥子,用水煎煮2次,合并浓缩液,将浓缩液减压浓缩、喷雾干燥得芥子提取物;
S2、取丁香,以87wt%甲醇溶液提取2次,再用乙醚萃取,回收溶剂,将溶剂减压浓缩、喷雾干燥得丁香提取物;
S3、取石莼,加工成石莼粉溶液,加入木瓜蛋白酶在pH为6.7,温度为53℃下酶解3h,经真空浓缩,再用乙醇沉淀并在4300r/min的转速下旋转16min,将沉淀物用丙酮洗脱并喷雾干燥,得石莼提取物;
S4、将芥子提取物、丁香提取物和石莼提取物混合均匀即得防腐制剂。
本实施例在制备时,将各原料研磨干燥成粉末状混合物即可。
本实施例原料来源广泛,成本低廉,贮存期2-3年,具有较好的保健作用,尤其对于Ⅱ型糖尿病具有较好的降低血糖的效果。本实施例以园艺黄荆叶作为主植物性成分,穗花牡荆种子、密花千屈菜、桑叶、显齿蛇葡萄叶、黄芪叶作为辅助植物性成分,含有众多具有生物活性的化学成分,配合作用具有较好的降血糖效果。本实施例另加入白芸豆、鹰嘴豆、亚麻籽、藜麦、燕麦、荞麦等营养补充物,能够丰富本实施例的保健功效,其与园艺黄荆种子等植物性成分具有协效作用,能够显著提高本实施例降低血糖的效果。本实施例另加入防腐制剂,选择芥子提取物、丁香提取物和石莼提取物的中药复合物,根据每种中草药的不同特性,分别提取分离中草药有效成分后配制而成,使三种中草药的药理作用起到相辅相成的效果,有效控制病原微生物的生长繁殖及传播,提高本实施例的保质期,同时提高本实施例的口感和风味。
测试本实施例的降糖效果:随机选取40-60岁之间的Ⅱ型糖尿病患者400名,每位Ⅱ型糖尿病患者于每天晚饭后开水冲服本实施例配制的含有园艺黄荆的固体饮料50-100g,连续服用45天后,上述100名Ⅱ型糖尿病患者中,364名患者的血糖水平有了明显地降低,36名患者的血糖水平控制在平稳状态,不再上升。由此可知本实施例具有降血糖效果显著的特点,且适于Ⅱ型糖尿病人长期食用。
实施例5
一种含有园艺黄荆的固体饮料,按照组份的质量份数配比包括下述原料:园艺黄荆叶14份、穗花牡荆种子6份、密花千屈菜2.5份、桑叶3份、显齿蛇葡萄叶2.4份、黄芪叶4份、魔芋7份、花生5份、紫薯3份、桑叶2份、柑橘纤维5份、白芸豆9份、鹰嘴豆4份、亚麻籽3.5份、藜麦2.5份、燕麦3份、荞麦5份、防腐制剂0.7份。
其中,所述防腐制剂的制备方法包括下述步骤:
S1、取芥子,用水煎煮2次,合并浓缩液,将浓缩液减压浓缩、喷雾干燥得芥子提取物;
S2、取丁香,以88wt%甲醇溶液提取2次,再用乙醚萃取,回收溶剂,将溶剂减压浓缩、喷雾干燥得丁香提取物;
S3、取石莼,加工成石莼粉溶液,加入木瓜蛋白酶在pH为6.8,温度为54℃下酶解3h,经真空浓缩,再用乙醇沉淀并在4400r/min的转速下旋转19min,将沉淀物用丙酮洗脱并喷雾干燥,得石莼提取物;
S4、将芥子提取物、丁香提取物和石莼提取物混合均匀即得防腐制剂。
本实施例在制备时,将各原料研磨干燥成粉末状混合物即可。
本实施例原料来源广泛,成本低廉,贮存期2-3年,具有较好的保健作用,尤其对于Ⅱ型糖尿病具有较好的降低血糖的效果。本实施例以园艺黄荆叶作为主植物性成分,穗花牡荆种子、密花千屈菜、桑叶、显齿蛇葡萄叶、黄芪叶作为辅助植物性成分,含有众多具有生物活性的化学成分,配合作用具有较好的降血糖效果。本实施例另加入白芸豆、鹰嘴豆、亚麻籽、藜麦、燕麦、荞麦等营养补充物,能够丰富本实施例的保健功效,其与园艺黄荆种子等植物性成分具有协效作用,能够显著提高本实施例降低血糖的效果。本实施例另加入防腐制剂,选择芥子提取物、丁香提取物和石莼提取物的中药复合物,根据每种中草药的不同特性,分别提取分离中草药有效成分后配制而成,使三种中草药的药理作用起到相辅相成的效果,有效控制病原微生物的生长繁殖及传播,提高本实施例的保质期,同时提高本实施例的口感和风味。
测试本实施例的降糖效果:随机选取40-60岁之间的Ⅱ型糖尿病患者500名,每位Ⅱ型糖尿病患者于每天晚饭后开水冲服本实施例配制的含有园艺黄荆的固体饮料50-100g,连续服用45天后,上述100名Ⅱ型糖尿病患者中,458名患者的血糖水平有了明显地降低,42名患者的血糖水平控制在平稳状态,不再上升。由此可知本实施例具有降血糖效果显著的特点,且适于Ⅱ型糖尿病人长期食用。
如上所述,尽管参照特定的优选实施例已经表示和表述了本发明,但其不得解释为对本发明自身的限制。在不脱离所附权利要求定义的本发明的精神和范围前提下,可对其在形式上和细节上作出各种变化。
Claims (7)
1.一种含有园艺黄荆的固体饮料,其特征在于,按照组份的质量份数配比包括下述原料:园艺黄荆叶13-15份、穗花牡荆种子4-7份、密花千屈菜2-3份、桑叶2-4份、显齿蛇葡萄叶2-3份、黄芪叶2-5份、魔芋5-10份、花生3-6份、紫薯2-4份、桑叶1-3份、柑橘纤维3-7份、白芸豆6-11份、鹰嘴豆2-5份、亚麻籽3-4份、藜麦2-3份、燕麦2-4份、荞麦3-6份、防腐制剂0.5-1份。
2.根据权利要求1所述的含有园艺黄荆的固体饮料,其特征在于,按照组份的质量份数配比包括下述原料:园艺黄荆叶13.5-14.5份、穗花牡荆种子5-6.5份、密花千屈菜2.2-2.7份、桑叶2.4-3.8份、显齿蛇葡萄叶2.1-2.6份、黄芪叶3-4.5份、魔芋6-8份、花生4.5-5.5份、紫薯2.3-3.6份、桑叶1.8-2.6份、柑橘纤维4-6份、白芸豆8-10份、鹰嘴豆3-4.5份、亚麻籽3.2-3.7份、藜麦2.3-2.6份、燕麦2.5-3.5份、荞麦4-5.5份、防腐制剂0.6-0.9份。
3.根据权利要求1所述的含有园艺黄荆的固体饮料,其特征在于,按照组份的质量份数配比包括下述原料:园艺黄荆叶14份、穗花牡荆种子6份、密花千屈菜2.5份、桑叶3份、显齿蛇葡萄叶2.4份、黄芪叶4份、魔芋7份、花生5份、紫薯3份、桑叶2份、柑橘纤维5份、白芸豆9份、鹰嘴豆4份、亚麻籽3.5份、藜麦2.5份、燕麦3份、荞麦5份、防腐制剂0.7份。
4.根据权利要求1-3任一项所述的含有园艺黄荆的固体饮料,其特征在于,所述防腐制剂的制备方法包括下述步骤:
S1、取芥子,用水煎煮2-3次,合并浓缩液,将浓缩液减压浓缩、喷雾干燥得芥子提取物;
S2、取丁香,以甲醇溶液提取1-2次,再用乙醚萃取,回收溶剂,将溶剂减压浓缩、喷雾干燥得丁香提取物;
S3、取石莼,加工成石莼粉溶液,加入木瓜蛋白酶进行酶解,经真空浓缩,再用乙醇沉淀并旋转15-20min,将沉淀物用丙酮洗脱并喷雾干燥,得石莼提取物;
S4、将芥子提取物、丁香提取物和石莼提取物混合均匀即得防腐制剂。
5.根据权利要求4所述的含有园艺黄荆的固体饮料,其特征在于,S2中,甲醇溶液的质量分数为85-90wt%。
6.根据权利要求4所述的含有园艺黄荆的固体饮料,其特征在于,S3中,酶解中,pH为6.5-7,温度为50-55℃,时间为3-4h。
7.根据权利要求4所述的含有园艺黄荆的固体饮料,其特征在于,S3中,旋转的转速为4000-4500r/min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911354309.XA CN113016972A (zh) | 2019-12-25 | 2019-12-25 | 一种含有园艺黄荆的固体饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911354309.XA CN113016972A (zh) | 2019-12-25 | 2019-12-25 | 一种含有园艺黄荆的固体饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113016972A true CN113016972A (zh) | 2021-06-25 |
Family
ID=76458037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911354309.XA Pending CN113016972A (zh) | 2019-12-25 | 2019-12-25 | 一种含有园艺黄荆的固体饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113016972A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435535A (zh) * | 2014-11-11 | 2015-03-25 | 郑玉柱 | 一种治疗ⅱ型糖尿病的保健药品 |
CN105211853A (zh) * | 2015-09-21 | 2016-01-06 | 河南科技大学 | 降糖保健组合物、冲剂及其制备方法 |
CN105767398A (zh) * | 2016-05-16 | 2016-07-20 | 黄林 | 臭黄荆养身茶 |
CN106107461A (zh) * | 2016-07-26 | 2016-11-16 | 江西本草天工生物技术有限公司 | 一种适合高血糖人群食用系列食品及其制备方法 |
CN108522969A (zh) * | 2018-04-08 | 2018-09-14 | 深圳市自然道生物科技有限公司 | 一种可降血糖的复方营养粉剂 |
CN108813350A (zh) * | 2018-07-09 | 2018-11-16 | 河北东方韵健康管理股份有限公司 | 一种降血糖、辅助治疗糖尿病的面条的配方及其制备工艺 |
-
2019
- 2019-12-25 CN CN201911354309.XA patent/CN113016972A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435535A (zh) * | 2014-11-11 | 2015-03-25 | 郑玉柱 | 一种治疗ⅱ型糖尿病的保健药品 |
CN105211853A (zh) * | 2015-09-21 | 2016-01-06 | 河南科技大学 | 降糖保健组合物、冲剂及其制备方法 |
CN105767398A (zh) * | 2016-05-16 | 2016-07-20 | 黄林 | 臭黄荆养身茶 |
CN106107461A (zh) * | 2016-07-26 | 2016-11-16 | 江西本草天工生物技术有限公司 | 一种适合高血糖人群食用系列食品及其制备方法 |
CN108522969A (zh) * | 2018-04-08 | 2018-09-14 | 深圳市自然道生物科技有限公司 | 一种可降血糖的复方营养粉剂 |
CN108813350A (zh) * | 2018-07-09 | 2018-11-16 | 河北东方韵健康管理股份有限公司 | 一种降血糖、辅助治疗糖尿病的面条的配方及其制备工艺 |
Non-Patent Citations (1)
Title |
---|
侯红萍: "《发酵食品工艺学》", vol. 1, 中国协和医科大学出版社, pages: 225 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101433188B1 (ko) | 아미노산, 활성종합비타민 및 한방생약재를 함유하는 숙취해소용 조성물 및, 그 제조방법 | |
KR101880894B1 (ko) | 혼합 생약제 추출물을 유효성분으로 포함하는 숙취해소, 피로회복 및 면역력 증강용 식품 조성물 | |
JP6463504B2 (ja) | 発毛促進、脱毛緩和及び改善、血糖調節、胃腸障害の症状緩和及び改善用健康補助食品 | |
KR101751211B1 (ko) | 남성 성기능 개선용 조성물, 이를 유효성분으로 포함하는 남성 성기능 개선용 기능성 식품 조성물 및 이의 제조방법 | |
KR20060106190A (ko) | 메밀을 이용한 기능성 식초 제조방법과 그 식초 및식초음료 | |
KR101166883B1 (ko) | 당귀, 천궁, 갈근, 작약, 숙지황, 황기, 홍삼, 건강, 감초, 계피 및 대추로 이루어진 한방 혼합 침출차 조성물 및 그 제조방법 | |
KR101788253B1 (ko) | 고량강, 풀솜대 및 흑마늘을 유효성분으로 포함하는 남성 성기능 개선용 조성물 | |
KR101520332B1 (ko) | 천연물 약재가 함유된 기능성 커피 및 이의 제조방법 | |
KR20140034620A (ko) | 식물 추출물을 포함하는 당뇨병 예방 또는 개선용 조성물 | |
CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
KR20110056908A (ko) | 다시마, 함초, 귤피, 당귀, 옥수수수염, 뽕잎 및 삼백초으로 이루어진 한방 혼합 침출차 조성물 및 그 제조방법 | |
KR101647917B1 (ko) | 초석잠 추출물을 포함하는 약재 추출액과 밤 약술 및 그 제조방법 | |
KR100923043B1 (ko) | 한방생약 혈압치료제 및 그 제조방법 | |
CN105902857A (zh) | 一种黄芪玉米须枸杞子降血糖口服液及其制备方法 | |
KR102452902B1 (ko) | 한약재 토종 약술 및 그 제조방법 | |
KR102491108B1 (ko) | 홍삼 조청 제조 방법 및 이를 이용해 제조된 홍삼 조청 | |
CN108260682A (zh) | 一种降血糖、降血脂和降血压的保健茶 | |
CN113016972A (zh) | 一种含有园艺黄荆的固体饮料 | |
KR102136053B1 (ko) | 허브추출물을 유효성분으로 하는 숙취해소용 조성물 및 이를 함유하는 음료 | |
KR101327802B1 (ko) | 장어 발효액 및 그 제조방법 | |
CN106212783A (zh) | 有机茶叶葛藤叶薯叶配方红茶 | |
KR20200132274A (ko) | 생강을 이용한 건강식품 제조방법 | |
KR20110029280A (ko) | 한방비누 조성물 | |
KR102636322B1 (ko) | 고추장 굴비의 제조방법 및 이에 의해 제조된 고추장 굴비 | |
KR20180121435A (ko) | 원적외선 증류수가 포함되는 발효 흑한방약재 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210625 |
|
RJ01 | Rejection of invention patent application after publication |